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Does the doctrine of double effect apply to the prescription of Nembutal?
Syme v the Medical Board of Australia

The doctrine of double effect (also known as the principle of double effect or just
double effect) is a principle of crucial importance in law, medicine and military ethics.
In medicine, the principle is generally accepted to apply in cases where the
treatment necessary to relieve pain and physical suffering runs the risk of hastening
the patient’s death. More controversially, it has also been used as a justification for
withdrawal of treatment from living individuals 1 and physician assisted suicide. 2

This paper analyses the findings of the controversial Victorian Civil and
Administrative Tribunal (VCAT) hearing Syme v the Medical Board of Australia. 3 In
that hearing, Dr. Rodney Syme, an Australian urologist and euthanasia advocate,
was defending his practice of prescribing a nembutal to terminally ill patients. Syme
claimed that he prescribed the drugs with the intention of relieving their existential
suffering, and not to assist in suicide; he argued that the doctrine of double effect
(DDE) could be applied. Pace VCAT, I will argue that there are good reasons to see
this as an illegitimate application of DDE. I will argue that a close scrutiny of Syme’s
actions suggests that he intended to give patients the option of suicide. In doing this,
we have reason to say he intended a bad effect, and, therefore, that DDE did not
apply. Furthermore, it could be argued that Syme was achieving a good effect by
means of the bad effect when he prescribed Nembutal. On the traditional formulation
of DDE, this is impermissible. I conclude my analysis with a brief discussion of the
comparison made by the Tribunal between Syme’s actions and the practice of
palliative sedation.

The case demonstrates the crucial importance of analysing an agent’s ‘intention’ and
the ‘effects’ of their actions when applying DDE. Ethicists and, indeed, the judiciary,
need to attend to the ethical complexities of DDE when they assess the applicability
of DDE to end of life care. If they fail to do this, the doctrine risks losing its legitimacy
as an ethical principle. 4

The Doctrine of Double effect (DDE)

DDE is a philosophical concept often employed when evaluating the morality of
actions. It rests on the basic conviction that in morality intentions matter, and that a
person’s intentions to some extent determine whether their actions are moral or
immoral. There are various formulations of the doctrine, depending on which ethical
or legal tradition you are approaching it from. We can nevertheless posit a generic
definition along the following lines:
The doctrine of double effect states that, where certain criteria are met, a
person acts ethically when acting to bring about a good or morally neutral
effect, even if her action also has certain foreseen, though not intended or
desired, bad effects.
An important phrase in the above definition is “where certain criteria are met”.
Depending on the tradition you work in, these criteria will vary. The traditional
formulation of the doctrine, adopted by Beauchamp and Childress, 5 McIntyre, 6
Bennett 7 and Uniacke 8, is accompanied by the following criteria:

1. The act itself must be good or at least morally neutral.

2. The agent must not intend the bad effect.
3. The bad effect must not be used as a means to achieve the good effect.
4. The ‘goodness’ of the good effect must outweigh to the ‘badness’ of the bad
effect, and there must be no other reasonable way to attain the good effect.

In the case in question, VCAT was working with a traditional formulation of double
effect rather than positing a consequentialist variety of the doctrine. Specifically, the
Tribunal took double effect to refer to the pursuit of a good, “primary (intended)
purpose”, despite the fact that there is a negative, “secondary (unintended)
consequence” that follows from it [33, 44]. A consequentialist view of double effect
might involve a rejection of premise 3 of the aforementioned criteria, as according to
consequentialism, it is permissible to achieve a good effect by means of a bad effect.
Indeed, there are commentators in the double effect literature who advocate this
view. 9 Yet from the discussion of double effect in the hearing it is clear that the
Tribunal accepted all the premises of the traditional formulation of the doctrine. In the
interest of fairness, I will adopt the traditional formulation of the doctrine for my
discussion, as this was the formulation that the Tribunal intended to apply.

Unfortunately the doctrine of double effect is often carelessly summarised and
important criteria are omitted. 10 Granted, there is much disagreement about the
nature of double effect, but many commentators will not even acknowledge the
relevant debates. 11

A legitimate application of the doctrine in a medical context would be chemotherapy.
In chemotherapy, a care team administers toxic drugs to the patient that may lead to

the patient’s death through the suppression of their immune system. The aim of the
treatment, nevertheless, is to cure cancer or reduce symptoms, and the inimical
side-effects for the patient are foreseen but unintended. In this case, it is appropriate
to describe chemotherapy as a treatment (something aimed at improving the
patients’ prognosis) rather than a deliberately harmful intervention. The primary
intent of the doctor is to cure or treat rather than to harm.

Suffice to say that the intentions of an agent are highly significant in the way we
choose to characterise their actions. Action-descriptions are more than just
categorisations of physical events, and we always should think about what the
intention of an agent is. The question I want to consider, however, is “does DDE
apply to the prescription of Nembutal?”.

Syme v The Medical Board of Australia

The VCAT hearing Syme vs the Medical Board of Australia3 centred on Melbourne
urologist and euthanasia activist Rodney Syme. The MBA had been made aware
that Syme was prescribing barbiturates (specifically, Nembutal) to patients who were
terminally ill, so as to give them “a sense of control” over the end of their lives. The
MBA’s Immediate Action Committee found that Syme posed “a serious risk to
persons”, and placed a condition on Syme’s license that prevented him from
engaging in medical care “that has the primary purpose of ending a person’s life” [4].
This was intended to prevent him from prescribing Nembutal to any more patients.

Syme appealed the ruling to the Victorian Civil and Administrative Tribunal (VCAT).
Syme’s essential claim was that in administering Nembutal to patients he was not
acting with the intent of ending their lives, but merely giving them a sense of control
over their own deaths. Death, he suggested, was only a foreseen, unintended sideeffect of his actions. His primary intent was to relieve their existential suffering.

Despite MBA’s arguments to the contrary, VCAT found in favour of Syme. The
tribunal ruled that his actions were consistent with the principle of double effect, and
that the MBA was wrong to suggest that Syme, in administering Nembutal, was
causing (or at least intending to cause) the death of the patient.

In the ruling, the Tribunal said that Syme’s intention was to “to give the patient
control” over the end of their lives, rather than to assist them in suicide. Syme told
the Tribunal that patients were known not to consume Nembutal even when it was
readily available to them, and that the mere possession of the drug was enough to
allay their fears of a painful death. The Tribunal saw this as convincing evidence that
he was not intending for them to ingest the drug. Furthermore, the tribunal saw
Syme’s actions as being analogous to the practice of terminal sedation in palliative
care:

“The Tribunal agrees that there is a logical analogy between the principle of double
effect used in palliative care; and the prospect that a patient may elect to ingest
Nembutal, the latter effectively representing the same kind of secondary effect as the
hastening of death which ...occurs when terminal sedation is used. The only real
difference is one of timing. When Nembutal is ingested in the requisite dose, the

process leading to death is quick and without the further trauma or complications
which can be associated with terminal sedation” [41].

A Critique
The problems raised in this case are significantly more complex than VCAT has
acknowledged. In particular, it raises questions about the nature of intention and the
relationship between the bad effects and good effects of our actions. In media
commentary on the case, the comparison was made between Syme’s actions and
the supply of a loaded gun to someone so they could “shoot themselves if they
wanted to”. 12 While there are limitations to this analogy, there are, nevertheless,
good reasons to view Syme’s actions as similar, if not morally equivalent, to more
salient cases of assistance in dying.

It is important to clarify what Syme believed the patients would do once they had
access to Nembutal. After all, if we are considering what Syme “intended”, we need
to consider how he thought the patients would act in conditions where they had
ready access to the drug. Syme stated that he believed the drug would not be used
for suicide unless it was absolutely needed to end unbearable pain or suffering.
What’s more, he had given Nembutal to hundreds of patients over the years, and
only 40% had consumed it. He described his practice in this way:
“I can say that categorically, that (sic) my intention is to give a sense of control and
by so doing to ease their suffering... by the time I make the assessment that they
need to have possession of the medication I am confident that they will not do that
unless they feel it absolutely necessary to use it” [17].

He believed, in other words, that the majority of patients would not ingest the drug.

The problematic ‘flip-side’ of this statement is that he also believed a significant
minority of patients would ingest the drug. Of the dozens or hundreds of patients he
prescribed Nembutal to, there was an expectation that at least several of them
would, where it had become “absolutely necessary”, consume the barbiturates.

Syme claims, however, that even in these cases, his primary intention was to relieve
suffering, and not to assist with death. Death was only even an unintended,
secondary consequence [16, 19]. In testing Syme’s claims, then, we need to ask,
“did he ever intend for patients to take the drug, or, at least, have the possibility of
taking the drug?”

To answer this, we should describe Syme’s intention in the most specific way
possible, rather than staying at the level of generalities. Descriptions of intention, just
like descriptions of action, should be sufficiently specific to perform the explanatory
function that they are intended to do. 13 By way of example, I could describe the
intention of act of as rescue as being “to help another person”; yet this description is
far too abstract and ambiguous. A more appropriate, specific description, would be
something like, “to pull the drowning child out of the pool”, or “to rescue the elderly
man from the burning house” (or whatever the act of rescue is aimed at achieving).

Syme provided a generic description of his own intention when he stated that he
aimed to “give patients a sense of control”. The trouble with this description is that it
does not pick out what makes his actions different from other ways of “giving patients

a sense of control”, such as by allowing them to choose between different treatment
options that may or may not increase their life expectancy, or by ensuring that they
have the opportunity to die at home if they so wish. Presumably, if we are looking for
an account of intention that picks out what is distinctive about the act of prescribing
Nembutal, we are warranted in providing a more specific description. Relieving
suffering was the indirect, general goal of prescription; yet “giving the patient the
option of suicide” was the particular means by which a sense of control was attained.
And Syme himself indicated that when he prescribed Nembutal to patients, he did so
knowing that “the person could use this drug to end their life” [17]. At the most basic
level, then, we can say that Syme’s specific aim at the time of prescription was to
“give patients the option of committing suicide”. While it may be true that his ultimate,
generic aim was to give patients a sense of control, Syme’s immediate, particular
aim at the time of prescription was to “give patients the option of suicide”.

But is an agent’s immediate, particular aim equivalent to the intended effect of their
actions? Yes, I argue. Intended effects just are aims, and insofar as something is
intended as a direct and immediate consequence, then it can be said to be part of
the intent of an agent. Importantly, this is not to deny Syme’s own description of his
actions; it is merely to cash out his description in a more specific way, a way that
appropriately captures what is distinctive about the act of prescribing Nembutal.

The problem for VCAT is that, if I am correct, Syme was intending a bad effect,
namely, “giving patients the option of committing suicide”. This being the case, he
violated criterion 2 of the principle of DDE.

An interlocutor may, however, claim that that there is a difference between giving a
patient the possibility of suiciding and actually assisting them in suicide. In the former
you are merely intending that someone have the possibility of doing something,
whereas in the latter you have the intention that they actually do it. If we accept this
distinction, then it is not clear that criteria 2 is violated. Intending that “someone
might commit suicide” need not be taken to be equivalent to intending a bad effect.
Or so it might be argued.

One way to respond to this objection would be reject the intention-splitting that is
involved in it. We might say that there is no real distinction between modal intentions
and real intentions. It is mere casuistry, we might suggest, to claim that there is a
difference between willing that an evil might occur and willing that it actually occurs.

An alternative response, and the one I would advocate, is to suggest that a bad
effect is still being intended. I would concede that in the two cases the agent has a
different object in view. In one case, the intention is that “that the patient commit
suicide”; in the other case, the intention is that “the patient might commit suicide”.
Yet even so, both of these states of affairs are bad. Even though in the latter case
the patient might not commit suicide, it is still bad that he “might commit suicide”. If
suicide is taken to be something bad – and this seems to be presupposed by anyone
who takes the traditional account of DDE not to apply to active euthanasia – then the
state of affairs in which one “might commit suicide” should also be considered as
something bad. And this is precisely what Syme was intending in this case.

Even if – for arguments sake – we take Syme’s intentions to be benign, it seems that
he fails to meet criterion 3 of the traditional formulation, namely, that the good effect

must not be produced by means of the bad effect. Let’s suppose that Syme’s
intention was solely to minimize suffering by virtue of “giving the patient a sense of
control”. We might, like the Tribunal, give Syme the benefit of the doubt. Even in this
situation, it seems that “the good effect is being achieved by the bad effect”. Syme
relieved patients’ suffering by giving them the possibility of committing suicide. This
good effect – gaining a sense of control – is brought about by the bad effect –
providing patients with the possibility of suicide. Or, to be more specific, the good
effect is rationally dependent on the bad effect. The patient’s belief that they are in
control of their lives is grounded in the fact that they can consume a lethal dose of
Nembutal if they wish. And this state of affairs is something bad. It would be different
if pain relief were achieved by helping the patient to accept the loss of control that
they were experiencing. Yet in this case, the relief of suffering is achieved by
providing them with the option of suicide, and not through some form of existential
therapy.

More could be said about intention and rational dependency. And I do not purport to
have provided a knock-down demonstration of the invalidity of DDE in Syme’s case.
This is in part because it is difficult to say with absolute certainty what he intended.
Yet I take it that there are good reasons to at least doubt VCAT’s application of the
doctrine. And this in itself is significant, considering that Tribunal was fairly
unequivocal in its application of DDE.

In its ruling, the Tribunal relied heavily on an analogy between “palliative sedation”
and the prescription of Nembutal for patients with existential distress. It is

appropriate, therefore, to conclude with a brief discussion of the notion of “palliative
sedation”.

Palliative sedation, in a clinical context, refers to the monitored use of medications to
induce a state of decreased or absent awareness in a patient experiencing otherwise
intractable suffering. 14 It is typically used in an end-of-life context, where other
treatments have proved insufficient and the goals of care legitimate its use.
Pharmacological interventions are used to bring about levels of sedation ranging
from mild (patient is somnolent) to intermediate (patient is in a stupor) to deep
(patient is comatosed). In such states, refractory symptoms, delirium, dyspnoea, pain
and convulsions can be significantly relieved or entirely eradicated. When conducted
in conformity with professional ethical standards such as those of the European
Association of Palliative Care (EAPC),14 the drugs are titrated to achieve relief of
symptoms, and not to hasten death.

In its ruling, the Tribunal attempted to distinguish between licit and illicit forms
palliative sedation [32, 40-42]. They held that sedation is permissible where the
primary intention is the relief of suffering; the hastening of death must only ever be a
“secondary (unintended) consequence” of the treatment [32]. Where the hastening of
death is the primary intention, sedation is impermissible [41-42]. The Tribunal
compared Syme’s actions to licit forms of palliative sedation. Just as in licit palliative
sedation there is a potential though unintentional hastening of death, so to in Syme’s
case there is a potential though unintentional hastening of death. 15 “The only real
difference”, to quote the ruling, “is one of timing”.

The use of an analogy involving palliative sedation by the Tribunal is problematic, in
part because palliative sedation is itself has been described as a “source of restless
ethical debate”. 16 While the Tribunal attempted to make a generalisation about
intentions in palliative sedation, there is significant controversy about what cases of
sedation count as intentional hastening of death, and what cases count as mere
symptom relief. Some may, for example, believe that palliative sedation coupled with
the withholding of hydration is ethically unproblematic. 1718 Others, however, would
argue that, for patients who are only afflicted by existential suffering and have no
terminal illness, palliative sedation coupled with the withholding of hydration counts
as an intentional hastening of death. 19 The effects of dehydration will cause death,
and such results of a treatment decision should be considered intentional if not
carried out within the context of a terminal illness and/or a situation of medical
futility. 20

But aside from this controversy, there is a clear disanalogy between the drugs and
doses typically involved in palliative sedation and those involved in Syme’s
prescriptions. In palliative sedation in Australia, benzodiazepines, general
anaesthetics and (rarely) barbiturates are used to induce a state of mild to deep
sedation in the patient. The doses are titrated, such that the appropriate amounts of
the drug are administered to treat symptoms, while not, for example, causing cardiac
or respiratory arrest. The drug provided by Syme, in contrast, was Nembutal – a drug
that when provided in a sufficient dose is lethal. And in the dosage that was
prescribed by Syme (9g capsules), it was capable of doing nothing other than killing
the patient. To quote Ian Maddocks’ expert testimony, “there is no other purpose for
ingesting [a 9g dose of Nembutal] and whenever taken, it will cause death” [26].

I, therefore, would argue that it is unhelpful to attempt (as the Tribunal attempted) to
justify Syme’s actions by reference to an analogy with palliative sedation. The
distinction between the application of double effect in palliative sedation and the
application of double effect in Syme’s case is far more than mere “timing”. It
concerns the fundamental difference in the nature (or, to use the term of Tribunal,
“purpose”) of the treatment involved. In one case the intervention is by its very nature
palliative. Studies suggest that in an Australian context the practice is not used to
shorten life (if anything, it may in fact prolong it). 21 In Syme’s case, the very drug
prescribed, when consumed, does nothing other than cause death.

Conclusion

The aim of this paper was not to provide an analysis of the ethics of euthanasia or
assisted suicide, but rather to consider where double effect might apply in end of life
care. I have argued that, in the case of Syme, there are good reasons to suggest
that DDE does not apply. I argued that Syme’s intention was not merely to relieve
pain, but also to give the patient the option of committing suicide. I also suggested
that he was attempting to achieve a good effect by means of a bad effect. This being
the case, it is impermissible to apply DDE to Syme’s actions. His actions violate key
criteria of the traditional definition of DDE.
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